Deepa Joseph

Deepa Joseph

Auto-generated profile, based on publicly available information

Deepa Joseph

Department of Radiation Oncology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2018 in South Asian Journal of Cancer
Verified
Journal Article
Open access
PDF file
DVDeepthi Valiyaveetti
Deepthi Valiyaveetti
MMMonica Malik
Monica Malik
DJDeepa M. Joseph
Deepa M. Joseph
SASyed Fayaz Ahmed
Syed Fayaz Ahmed
SKSyed Akram Kothwal
Syed Akram Kothwal
MVM. Vijayasaradhi
M. Vijayasaradhi
Background: Retrospective evidence suggests that valproic acid (VPA), an antiepileptic drug, is associated with improved outcomes in glioblastoma. The exact mechanism of interaction of VPA with radiation and temozolomide (TMZ) is still unclear. Laboratory studies show that VPA can enhance tumor cell kill while at the same time protect the normal neural tissue. The aim of this study was to prospectively evaluate the benefit of VPA on outcomes in glioblastoma. Materials and Methods: In this single-arm prospective study, patients of glioblastoma were started on seizure prophylaxis with VPA (15–20 mg/kg/day) following maximal safe resection. All patients were treated with chemoradiation to a dose of 60 Gy in 30 fractions with concurrent TMZ followed by adjuvant TMZ for 6 cycles. VPA was continued during adjuvant treatment and follow-up. Survival analysis was done using Kaplan–Meier analysis. Results: Twenty patients were enrolled in the study. Median age was 47 years. M:F ratio was 3:1. Treatment was well tolerated with no grade 3/4 adverse events. 8/20 patients experience seizure episodes during treatment and/or follow-up which needed additional antiepileptic drugs for control. Median progression-free survival (PFS) and overall survival (OS) were 10 months and 16 months, respectively. Younger patients (age ≤45 years) showed a significantly better OS (25 months) versus older patients (8 months) (P = 0.002). Conclusions: Incidence of seizures on VPA prophylaxis was 40%. Median PFS and OS were comparable to historical controls. There was no significant treatment-related toxicity. The results need validation in larger prospective randomized studies.

1 November 2015 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
MMM. Malik
M. Malik
KAK.S. Akram
K.S. Akram
DJD. Joseph
D. Joseph
DVD. Valiyaveettil
D. Valiyaveettil
SAS.F. Ahmed
S.F. Ahmed

1 December 2015 in Asian Journal of Neurosurgery
Verified
Journal Article
Open access
PDF file
PLPavan Kumar Lachi
Pavan Kumar Lachi
MIMonica Irrakula
Monica Irrakula
SASyed Fayaz Ahmed
Syed Fayaz Ahmed
DJDeepa Joseph
Deepa Joseph
SPSuresh Pamidighantam
Suresh Pamidighantam
KNKotiyala V Jagannath Rao Naidu
Kotiyala V Jagannath Rao Naidu
Aim of the Study: This study was to analyze the clinical outcomes of brain stem glioma treated with radiation therapy (RT) in our institution. Material and Methods: Records of 48 patients with brainstem glioma treated between January 2007 and January 2013 were reviewed. Demographic variables, clinical variables, radiological findings and treatment details with respect to age, sex, location of tumor ( pontine Vs non pontine ), signs and symptoms, RT dose, follow up period and outcomes were recorded. Patients were subdivided into two groups based on their age, age =15 yrs (Group II). Results: The median age at diagnosis was 10 years (range 4-50). Male to female ratio was 11:10. Of the 48 cases analyzed, 27 patients (56%) were in group I and 21 (44%) were in group II. Radiologically, 90.5% had involvement of pons. 10 (21%) patients received RT dose >60 Gy and 38 (79 %) patients received RT dose of 54-60 Gy. Median overall survival was 7months (range 3-44 months). Median overall survival in Group I and Group II was 4 months and 10 months respectively (P = 0.042). Conclusions: Brain stem glioma in pediatric age group is associated with worse outcomes than in adults.

31 March 2021 in Radiation Oncology Journal
Verified
Journal Article
Open access
PDF file
MMMonica Malik
Monica Malik
DVDeepthi Valiyaveettil
Deepthi Valiyaveettil
DJDeepa Joseph
Deepa Joseph
The coronavirus disease 2019 (COVID-19) pandemic has profoundly impacted cancer care, research and residency training in oncology worldwide. Many countries canceled exams, shortened their residency program and medical school tenure. Traditional teaching and learning method has faced significant disruption during this time and the situation has pushed us to adapt to e-learning. Most national and international cancer meetings were converted into a virtual platform during this time. E-learning ensures a safe environment to maintain education during a pandemic. Digital technology-based learning is likely to be used effectively in oncology training even after the pandemic ends. Stakeholders should work towards standardizing e-learning into routine educational modules and create a system of credibility and accountability.

1 June 2020 in Radiation Oncology Journal
Verified
Journal Article
Open access
PDF file
MGManoj Gupta
Manoj Gupta
RARachit Ahuja
Rachit Ahuja
SGSweety Gupta
Sweety Gupta
DJDeepa Joseph
Deepa Joseph
RPRajesh Pasricha
Rajesh Pasricha
LPLaxman Pandey
Laxman Pandey
Purpose: Due to COVID 19 pandemic, the treatment of cancer patients has become a dilemma for every oncologist. Cancer patients are at an increased risk of immunosuppression and have a higher risk to acquire any infection. There are individual experiences from some centers regarding the management of cancer patients during such a crisis. So we have developed our institutional strategy to balance between COVID and cancer management. Materials and Methods: Radiation Oncology departmental meeting was held to prepare a consensus document on Radiotherapy schedules and department functioning during this pandemic. Results: Strategies were taken in form of following areas were steps need to be taken to decrease risk of infection, categorise treatment on the basis of priority, radiotherapy schedules modification, academic meetings and management of COVID positive patient/personnel in Radiation Oncology department. Conclusion: We hope to strike the balance in overcoming both the battles and emerge as winners. Stringent long term follow up will be done for assessing the response or any unforeseen treatment related sequelae.

30 March 2016 in Radiation Oncology Journal
Verified
Journal Article
Open access
PDF file
DJDeepa Joseph
Deepa Joseph
MIMonica Malik Irukulla
Monica Malik Irukulla
SASyed Fayaz Ahmed
Syed Fayaz Ahmed
DVDeepthi Valiyaveettil
Deepthi Valiyaveettil
SASyed Akram
Syed Akram
Joseph D, et al. Radiat Oncol J. 2016 Mar;34(1):76-80. http://dx.doi.org/10.3857/roj.2016.34.1.76